Chemical formula: C₂₂H₂₄ClFN₄O₃ Molecular mass: 446.902 g/mol PubChem compound: 123631
Gefitinib is indicated for:
Population group: only adults (18 years old or older)
Gefitinib is indicated as monotherapy for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Gefitinib is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
